NAGE FY 2025 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$423M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$129M+29.9% YoY

Gross Profit

$83M64.3% margin

Operating Income

$14M11.0% margin

Net Income

$17M13.4% margin

EPS (Diluted)

$0.20

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$13M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$106M

Total Liabilities

$30M

Stockholders' Equity

$77M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$129M	$100M	+29.9%
Gross Profit	$83M	$62M	+35.1%
Operating Income	$14M	$8M	+85.0%
Net Income	$17M	$9M	+103.3%